M. Luque

489 total citations
22 papers, 189 citations indexed

About

M. Luque is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, M. Luque has authored 22 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in M. Luque's work include Retinal Diseases and Treatments (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Lung Cancer Research Studies (4 papers). M. Luque is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Lung Cancer Research Studies (4 papers). M. Luque collaborates with scholars based in Spain, Chile and Argentina. M. Luque's co-authors include Guillermo Marshall, Gabriel Musante, José Luís Tapia, Waldemar F. Carlo, Javier Kattan, Pilar Blay, Yolanda Fernández, José M.P. Freije, Milagros Balbı́n and Emilio Esteban and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and BMC Cancer.

In The Last Decade

M. Luque

21 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Luque Spain	8	73	47	45	39	38	22	189
André Oberthür Germany	5	66 0.9×	61 1.3×	51 1.1×	35 0.9×	15 0.4×	11	203
Elpidoforos Sakkas Germany	7	99 1.4×	92 2.0×	23 0.5×	17 0.4×	16 0.4×	7	339
Katriina Parto Finland	8	61 0.8×	51 1.1×	75 1.7×	23 0.6×	36 0.9×	14	299
Katherine Josephs United Kingdom	8	19 0.3×	96 2.0×	24 0.5×	38 1.0×	74 1.9×	16	243
E.A. Dubil United States	7	34 0.5×	72 1.5×	33 0.7×	44 1.1×	21 0.6×	12	241
Prateek Gupta United States	8	74 1.0×	81 1.7×	20 0.4×	11 0.3×	145 3.8×	14	313
Kristen Whitaker United States	7	35 0.5×	34 0.7×	26 0.6×	74 1.9×	45 1.2×	11	229
Hakan Ozan Türkiye	12	28 0.4×	52 1.1×	47 1.0×	16 0.4×	18 0.5×	37	330
Angela C. Chen United States	10	16 0.2×	90 1.9×	15 0.3×	49 1.3×	26 0.7×	21	247
Per Frisk Sweden	9	18 0.2×	37 0.8×	77 1.7×	47 1.2×	13 0.3×	27	221

Countries citing papers authored by M. Luque

Since Specialization

Citations

This map shows the geographic impact of M. Luque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Luque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Luque more than expected).

Fields of papers citing papers by M. Luque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Luque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Luque. The network helps show where M. Luque may publish in the future.

Co-authorship network of co-authors of M. Luque

This figure shows the co-authorship network connecting the top 25 collaborators of M. Luque. A scholar is included among the top collaborators of M. Luque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Luque. M. Luque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez‐Recio, Sandra, Jordi Guardiola, Xavier Juanola, et al.. (2025). Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country. Clinical Infectious Diseases. 82(2). 282–290.

Pérez‐Recio, Sandra, et al.. (2023). Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting. The International Journal of Tuberculosis and Lung Disease. 27(4). 315–321. 1 indexed citations

Montero, Núria, M. Luque, Núria Sabé, et al.. (2021). Tuberculosis prevention in patients undergoing kidney transplantation: A nurse‐led program for screening and treatment. Transplant Infectious Disease. 23(4). e13603–e13603. 3 indexed citations

Camprubí, Daniel, Aina Gomila‐Grange, Laura Soldevila, et al.. (2020). Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by Real-time Polymerase Chain Reaction, XpertⓇMTB/RIF. Journal of Infection. 80(3). 298–300. 1 indexed citations

Luque, M., et al.. (2017). Hemangioma capilar retiniano yuxtapapilar bilateral: utilidad de aflibercept en el manejo de sus complicaciones. Archivos de la Sociedad Española de Oftalmología. 92(10). 477–480. 1 indexed citations

Luque, M., et al.. (2017). Eplerenona, un nuevo tratamiento para un viejo problema: retinosis pigmentaria asociada a edema macular recalcitrante. Archivos de la Sociedad Española de Oftalmología. 93(1). 38–41. 2 indexed citations

Sanmamed, Miguel F., Emilio Esteban, Ruth Zárate, et al.. (2017). Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours. Journal of Translational Medicine. 15(1). 62–62. 6 indexed citations

Luque, M., et al.. (2017). BIlateral juxtapapillary retinal capillary haemangioma: Usefulness of aflibercept in the management of its complications. Archivos de la Sociedad Española de Oftalmología (English Edition). 92(10). 477–480. 2 indexed citations

Luque, M., et al.. (2017). Eplerenone, a new treatment for an old problem: Retinitis pigmentosa with recalcitrant macular edema. Archivos de la Sociedad Española de Oftalmología (English Edition). 93(1). 38–41. 2 indexed citations

10.

Luque, M., José Luís Tapia, Guillermo Marshall, et al.. (2013). A risk prediction model for severe intraventricular hemorrhage in very low birth weight infants and the effect of prophylactic indomethacin. Journal of Perinatology. 34(1). 43–48. 47 indexed citations

11.

Blay, Pilar, Íñigo Santamaría, Ana S. Pitiot, et al.. (2013). Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer. 13(1). 243–243. 40 indexed citations

12.

Luque, M., Juan Cueva, Paula García‐Teijido, et al.. (2013). Breast cancer management in the elderly. Clinical & Translational Oncology. 16(4). 351–361. 7 indexed citations

13.

Marshall, Guillermo, et al.. (2012). Center variability in risk of adjusted length of stay for very low birth weight infants in the Neocosur South American Network. Jornal de Pediatria. 88(6). 524–30. 9 indexed citations

14.

Crespo, Guillermo, Marta Sierra, N. Villanueva, et al.. (2011). Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer. International Journal of Gynecological Cancer. 21(3). 478–485. 8 indexed citations

15.

Esteban, Emilio, Norberto Corral, Paula Jiménez Fonseca, et al.. (2010). Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias. Clinical & Translational Oncology. 12(8). 562–567. 4 indexed citations

16.

Esteban, Emilio, N. Villanueva, J. Fra, et al.. (2010). Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study. Investigational New Drugs. 29(6). 1459–1464. 4 indexed citations

17.

Barbarroja, Nuria, M. Luque, Laura M. López‐Sánchez, et al.. (2009). Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia. Experimental Hematology. 37(6). 679–691. 9 indexed citations

18.

Fonseca, Paula Jiménez, Emilio Esteban, M. Luque, et al.. (2008). Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy. Clinical & Translational Oncology. 10(7). 426–432. 3 indexed citations

19.

Esteban, Emilio, N. Villanueva, Yolanda Fernández, et al.. (2007). Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study. Investigational New Drugs. 26(1). 67–74. 16 indexed citations

20.

Esteban, Emilio, N. Villanueva, Norberto Corral, et al.. (2006). Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): Results of a prospective randomized study. Lung Cancer. 55(2). 173–180. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact